Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC)
CUSIP: 08205P209
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, par value $0.0001
- Shares outstanding
- 35,393,481
- Total 13F shares
- 6,877
- Share change
- -8,081
- Total reported value
- $73,241
- Price per share
- $10.83
- Number of holders
- 4
- Value change
- -$109,391
- Number of buys
- 2
- Number of sells
- 2
Quarterly Holders Quick Answers
What is CUSIP 08205P209?
CUSIP 08205P209 identifies BNTC - Benitec Biopharma Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 08205P209:
Top shareholders of BNTC - Benitec Biopharma Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13D/G
3/4/5
13F
|
Director, 10%+ Owner · Company |
44%
|
17,761,945
|
$249,200,088 | +$30,000,153 | 07 Nov 2025 | |
| FRANKLIN RESOURCES INC |
13D/G
13F
|
Company |
11%
|
3,751,709
|
$50,561,782 | -$5,287,404 | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13D/G
13F
|
Company |
10%
|
3,382,836
|
$44,484,293 | -$292,158,468 | 28 Nov 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
6%
|
2,120,672
|
$28,565,452 | — | 31 Dec 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
13D/G
|
Company |
5.5%
from 13D/G
|
1,850,000
|
$24,919,500 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.3%
|
1,174,758
|
$15,823,990 | — | 31 Dec 2025 | |
| HBM Healthcare Investments (Cayman) Ltd. |
13D/G
|
— |
4.5%
|
1,041,669
|
$14,156,282 | $0 | 31 Dec 2024 | |
| Nantahala Capital Management, LLC |
13D/G
13F
|
Company |
4.4%
|
1,038,371
|
$14,111,462 | $0 | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
2.8%
|
992,347
|
$13,366,914 | — | 31 Dec 2025 | |
| INFINITUM ASSET MANAGEMENT, LLC |
13F
|
Company |
2.5%
|
898,871
|
$12,107,792 | — | 31 Dec 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
2.2%
|
775,000
|
$10,439,250 | — | 31 Dec 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
2.1%
|
750,000
|
$10,102,500 | — | 31 Dec 2025 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
731,717
|
$9,856,228 | — | 31 Dec 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
1.8%
|
651,558
|
$8,776,486 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.7%
|
613,160
|
$8,259,265 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
453,375
|
$6,108,556 | — | 31 Dec 2025 | |
| Longaeva Partners L.P. |
13F
|
Company |
0.82%
|
290,000
|
$3,906,300 | — | 31 Dec 2025 | |
| AWM Investment Company, Inc. |
13F
|
Company |
0.8%
|
282,977
|
$3,811,700 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.79%
|
280,727
|
$3,781,392 | — | 31 Dec 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.74%
|
262,205
|
$3,531,900 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.69%
|
245,051
|
$3,300,837 | — | 31 Dec 2025 | |
| Steven Michael Oliveira |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,000,000
|
$3,044,300 | — | 28 Apr 2021 | |
| MYDA Advisors LLC |
13F
|
Company |
0.64%
|
225,000
|
$3,030,750 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.49%
|
174,041
|
$2,344,332 | — | 31 Dec 2025 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.43%
|
151,163
|
$2,036,166 | — | 31 Dec 2025 | |
| Burkehill Global Management, LP |
13F
|
Company |
0.42%
|
150,000
|
$2,020,500 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.36%
|
126,160
|
$1,699,375 | — | 31 Dec 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.28%
|
100,704
|
$1,356,483 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.28%
|
98,347
|
$1,324,734 | — | 31 Dec 2025 | |
| Lion Point Capital, LP |
13F
|
Company |
0.18%
|
62,000
|
$835,140 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.17%
|
58,812
|
$792,197 | — | 31 Dec 2025 | |
| Empery Asset Management, LP |
13F
|
Company |
0.16%
|
55,440
|
$746,777 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.13%
|
45,274
|
$609,841 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.1%
|
35,688
|
$480,717 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
31,612
|
$425,814 | — | 31 Dec 2025 | |
| Quadrature Capital Ltd |
13F
|
Company |
0.09%
|
31,481
|
$424,049 | — | 31 Dec 2025 | |
| J. Kevin Buchi |
3/4/5
|
Director |
—
mixed-class rows
|
138,910
mixed-class rows
|
$401,092 | — | 01 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.07%
|
23,211
|
$312,652 | — | 31 Dec 2025 | |
| Persistent Asset Partners Ltd |
13F
|
Company |
0.06%
|
20,753
|
$279,543 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.05%
|
18,779
|
$252,953 | — | 31 Dec 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.05%
|
17,668
|
$237,983 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
17,580
|
$236,803 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.05%
|
16,262
|
$219,049 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.04%
|
15,045
|
$202,656 | — | 31 Dec 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.04%
|
13,288
|
$178,000 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.04%
|
12,425
|
$167,365 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.03%
|
12,307
|
$165,775 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
12,125
|
$163,324 | — | 31 Dec 2025 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.03%
|
9,397
|
$126,578 | — | 31 Dec 2025 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.02%
|
8,232
|
$111,000 | — | 31 Dec 2025 |
Institutional Holders of Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) as of Q1 2026
As of 31 Mar 2026,
Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) was held by
4 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,877 shares.
The largest 4 holders included
GAMMA Investing LLC, SIGNATUREFD, LLC, True Wealth Design, LLC, and IFP Advisors, Inc.
This page lists
4
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
71
Q1 2026 holders
4
Holder diff
-67
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.